Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy

Condition:   Prostate Cancer Metastatic to Bone Interventions:   Drug: Radium-223 chloride;   Drug: Rhenium-188-HEDP Sponsor:   VU University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials